New chronic ITP therapy coming soon
Health Canada has approved Amgen Canada's Nplate (romiplostim), a recombinant thrombopoiesis stimulating protein used to increase platelet levels in adults with chronic immune (idiopathic) thrombocytopenic purpura (ITP).